Kawasaki's Rose

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 5
gptkbp:bfsParent gptkb:Jana_Plodková
gptkbp:advocates_for Kawasaki Disease Foundation
Kawasaki Disease Research Center
gptkbp:affects gptkb:Person
gptkbp:associated_with autoimmune response
gptkbp:caused_by gptkb:Kawasaki_disease
gptkbp:complications coronary artery aneurysm
gptkbp:current_use Mucocutaneous lymph node syndrome
gptkbp:discovered_by gptkb:Tomisaku_Kawasaki
gptkbp:distribution worldwide
gptkbp:end_of_life very low with treatment
gptkbp:events cardiology evaluation
echocardiogram
monitoring for coronary artery changes
gptkbp:first_described_by gptkb:1967
gptkbp:healthcare gptkb:battle
https://www.w3.org/2000/01/rdf-schema#label Kawasaki's Rose
gptkbp:is_a_resource_for gptkb:academic_journal
available online
support groups
awareness events
patient brochures
gptkbp:is_popular_in higher in Asian children
gptkbp:occurs_in approximately 20 per 100,000 children
gptkbp:public_awareness increased in recent years
Kawasaki Disease Foundation
gptkbp:research_focus genetic predisposition
environmental triggers
etiology
long-term outcomes
gptkbp:risk_factor male gender
age under 5
gptkbp:social_responsibility clinical criteria
conjunctival injection
cervical lymphadenopathy
changes in lips and oral cavity
fever lasting more than 5 days
hand and foot changes
polymorphous rash
gptkbp:symptoms fever
swollen lymph nodes
skin rash
red eyes
strawberry tongue
gptkbp:treatment intravenous immunoglobulin
aspirin
as soon as possible